DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Guerra L, Niespolo R, Di Pisa G. et al.
Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of
histopathologic response to neoadjuvant treatment in rectal cancer.
Abdom Imaging 2011;
36: 38-45 doi:10.1007/s00261–009–9594–8
We do not assume any responsibility for the contents of the web pages of other providers.